| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | 21,177 | 11,384 |
| Depreciation and amortization | 9,859 | 5,931 |
| Amortization of costs capitalized to obtain contracts | 932 | 594 |
| Amortization of operating lease right-of-use asset | 259 | 171 |
| Stock-based compensation expense, net of amounts capitalized | 39,985 | 25,118 |
| Non-cash interest expense, net | 727 | 181 |
| Convertible notes fair value adjustment | 0 | 0 |
| Derivative liability fair value adjustment | 0 | 0 |
| Loss on settlement of convertible notes | 0 | 0 |
| Gain on settlement of derivative liability | 0 | 0 |
| Gain on change in fair value of investments | 2,090 | 1,269 |
| Non-cash revenue from investments | 905 | 636 |
| Provision for credit losses | 825 | 350 |
| Accounts receivable, net | 8,890 | 1,206 |
| Prepaid expenses and other assets | 6,314 | 5,456 |
| Inventory | 6,078 | 1,616 |
| Costs capitalized to obtain contracts, net | 986 | 642 |
| Accounts payable | 3,540 | -2,585 |
| Accrued expenses and other current liabilities | -5,830 | -7,520 |
| Deferred revenue | 5,913 | 2,778 |
| Other liabilities, noncurrent | -294 | -194 |
| Net cash provided by operating activities | 51,830 | 25,383 |
| Cash paid for acquisition | 2,825 | 2,825 |
| Internally developed software | 4,538 | 3,498 |
| Purchase of property and equipment | 1,565 | 766 |
| Convertible note investment | 25,000 | 25,000 |
| Net cash used in investing activities | -33,928 | -32,089 |
| Proceeds related to tax withholdings on restricted stock settlements and the exercise of stock options and warrants | 50,770 | 29,570 |
| Taxes paid related to net settlement of equity awards | 47,292 | 25,767 |
| Proceeds from issuance of common stock in u.s. initial public offering, net of underwriting discounts and commissions | 0 | 0 |
| Payments of u.s. initial public offering issuance costs | 0 | 0 |
| Proceeds from issuance of convertible senior notes | 320,000 | 320,000 |
| Payments of debt issuance costs | 10,884 | 9,600 |
| Purchase of capped calls | 33,728 | 33,728 |
| Net cash provided by financing activities | 278,866 | 280,475 |
| Net increase in cash, cash equivalents, and restricted cash | 296,768 | 273,769 |
| Cash and cash equivalents at beginning of period | 160,459 | - |
| Cash and cash equivalents at end of period | 457,227 | - |
Life360, Inc. (LIFX)
Life360, Inc. (LIFX)